Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Neinor Homes | 1NN | Sep 27, 2024 | 14.78 | +0.68 |
Nekkar | 0TT | Sep 27, 2024 | 0.73 | -11.78 |
Nektar Therapeutics | ITH | Sep 27, 2024 | 0.99 | -3.37 |
NEL | D7G | Sep 27, 2024 | 0.42 | +1.39 |
Nel ASA Unsponsored ADR (Norway) | D7GA | Sep 27, 2024 | 11.60 | -1.69 |
Nelly Group | CD20 | Sep 27, 2024 | 2.19 | -0.91 |
Nelnet, Inc. | NIJ | Sep 27, 2024 | 99.50 | +1.02 |
NEMETSCHEK UNSP.ADR/0,2 | NEM0 | Sep 27, 2024 | 17.80 | +2.89 |
Nemetschek SE | NEM | Sep 27, 2024 | 93.25 | -1.53 |
NENT Group B | NEB | Sep 27, 2024 | 0.07 | +1.08 |
Neo Performance Materials Inc | N14 | Sep 27, 2024 | 5.36 | +2.49 |
NEO-NEON | N2L | Sep 27, 2024 | 0.03 | -1.72 |
Neodecortech S.p.a. | FM2 | Sep 27, 2024 | 3.05 | 0.00 |
Neoen S.A. | N1N | Sep 27, 2024 | 38.48 | -0.52 |
NEOENERGIA UNSP.ADR 1 | 2Q40 | Sep 27, 2024 | 10.90 | 0.00 |
Neogen Corporation | NG2 | Sep 27, 2024 | 14.80 | +0.68 |
NeoGenomics, Inc. | NG9 | Sep 27, 2024 | 13.00 | -2.26 |
Neolife | 8JB | Sep 27, 2024 | 0.05 | +1.87 |
Neometals Ltd | 9R9 | Sep 27, 2024 | 0.09 | -6.15 |
NEOMETALS LTD SP.ADS/10 | 9R91 | Sep 27, 2024 | 0.75 | -1.32 |
NEON EQUITY NA O.N. | D77 | Sep 27, 2024 | 1.75 | +12.90 |
NeonMind Biosciences Inc | 6UF0 | Sep 27, 2024 | 0.01 | 0.00 |
Neosperience S.p.a | Y8E | Sep 27, 2024 | 1.08 | 0.00 |
NEOTECH METALS CORP. | V690 | Sep 27, 2024 | 0.09 | -18.18 |
Nephros | NPJP | Sep 27, 2024 | 1.57 | -0.63 |
Neptune Digital Assets Corp. | 1NW | Sep 27, 2024 | 0.18 | +11.66 |
Nerds On Site Inc | 3NS | Sep 27, 2024 | 0.02 | 0.00 |
Nerdwallet Inc | 6OI | Sep 27, 2024 | 11.10 | -0.89 |
NervGen Pharma Corp | 9UA | Sep 27, 2024 | 1.58 | +1.94 |
Neste | NEF | Sep 27, 2024 | 16.94 | +2.05 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.